Patients taking GLP-1s had a 15-20% reduction in MACE (heart attack and stroke), which is consistent with clinical trials ...

At "science day" in a Philly courthouse, both sides of a potentially ground-shifting legal case discussed how the diabetes ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

Ozempic maker Novo Nordisk has developed a pill that can cause weight loss of up to 13% in three months, according to new ...

Dr. Iris Gorfinkel joins us with the latest health headlines. From Health Canada’s approval of the new COVID vaccine and whether to pair it with your flu shot, to American companies offering faster ...

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...

A PILL from the makers of Ozempic and Wegovy leads to faster and longer-lasting weight loss than the popular ‘skinny jabs’, a ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill.

The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows.

Discover what the supplement Lemme GLP-1 Daily does and whether its ingredients are really effective for weight and blood ...

At the heart of the case are the drugs in question: Ozempic, Wegovy ... These drugs have been the subject of dozens of rigorous trials, and produced more than 10 years of real-world evidence ...